Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (191-200 of 366) with videos related to

Pageof 37
Sort By:
Journal of the National Cancer Institute|September 1, 2011
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trialsJean Y Tang, Katrina M Spaunhurst, Rowan T Chlebowski, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 15, 2013
Walking speed, physical activity, and breast cancer in postmenopausal womenKaren Kwan, Rowan T Chlebowski, Anne McTiernan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Cancer|June 4, 2015
Estrogen and colorectal cancer incidence and mortalitySayeh Lavasani, Rowan T Chlebowski, Ross L Prentice, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 2013
Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiativeJennifer C Livaudais, Andrea Lacroix, Rowan T Chlebowski, et al.
Menopause (New York, N.Y.)|March 21, 2013
Estrogen alone and joint symptoms in the Women's Health Initiative randomized trialRowan T Chlebowski, Dominic J Cirillo, Charles B Eaton, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, JoAnn E Manson, et al.
The American Journal of Clinical Nutrition|August 23, 2013
Vitamin D intake and lung cancer risk in the Women's Health InitiativeTing-Yuan David Cheng, Andrea Z Lacroix, Shirley A A Beresford, et al.
Journal of Women'S Health (2002)|October 18, 2013
Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health InitiativeJane A Cauley, Rowan T Chlebowski, Jean Wactawski-Wende, et al.
Pageof 37

Showing results (191-200 of 366) with videos related to

Sort By:
Pageof 37
Journal of the National Cancer Institute|September 1, 2011
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trialsJean Y Tang, Katrina M Spaunhurst, Rowan T Chlebowski, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 15, 2013
Walking speed, physical activity, and breast cancer in postmenopausal womenKaren Kwan, Rowan T Chlebowski, Anne McTiernan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Cancer|June 4, 2015
Estrogen and colorectal cancer incidence and mortalitySayeh Lavasani, Rowan T Chlebowski, Ross L Prentice, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 2013
Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiativeJennifer C Livaudais, Andrea Lacroix, Rowan T Chlebowski, et al.
Menopause (New York, N.Y.)|March 21, 2013
Estrogen alone and joint symptoms in the Women's Health Initiative randomized trialRowan T Chlebowski, Dominic J Cirillo, Charles B Eaton, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, JoAnn E Manson, et al.
The American Journal of Clinical Nutrition|August 23, 2013
Vitamin D intake and lung cancer risk in the Women's Health InitiativeTing-Yuan David Cheng, Andrea Z Lacroix, Shirley A A Beresford, et al.
Journal of Women'S Health (2002)|October 18, 2013
Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health InitiativeJane A Cauley, Rowan T Chlebowski, Jean Wactawski-Wende, et al.
Pageof 37